blood loss Clinical Trials

35 recruitingLast updated: June 18, 2026

There are 35 actively recruiting blood loss clinical trials across 19 countries. Studies span Not Applicable, Phase 4, Phase 2, Phase 3, Phase 1, Early Phase 1. Top locations include Asyut, Egypt, Alexandria, Smouha, Egypt, Anderlecht, Belgium. Updated daily from ClinicalTrials.gov.


blood loss Trials at a Glance

35 actively recruiting trials for blood loss are listed on ClinicalTrialsFinder across 6 cities in 19 countries. The largest study group is Not Applicable with 15 trials, with the heaviest enrollment activity in Asyut, Alexandria, and Anderlecht. Lead sponsors running blood loss studies include Alexandria University, Assiut University, and Ascension Health.

Browse blood loss trials by phase

Treatments under study

About blood loss Clinical Trials

Looking for clinical trials for blood loss? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new blood loss trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about blood loss clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 35 trials

Recruiting
Not Applicable

EFFICACY OF INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION ON THE POSTOPERATIVE BLOOD LOSS IN PATIENTS UNDERGOING RARP FOR THE TREATMENT OF PROSTATE CANCER

Prostate Cancer (Adenocarcinoma)Blood Loss, PostoperativeErectile Function
St. Antonius Hospital Gronau362 enrolled3 locationsNCT06822036
Recruiting
Phase 1

Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury

Blood Loss, Surgical
University of Manitoba24 enrolled1 locationNCT01731444
Recruiting
Not Applicable

Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures

Blood Loss, Surgical
University Surgical Vascular40 enrolled1 locationNCT06647017
Recruiting
Phase 1

Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis

SurgeryPostoperative Blood Loss
Vanderbilt University Medical Center60 enrolled1 locationNCT05774717
Recruiting
Phase 3

Tranexamic Acid for Reduction of Transfusion in Abdominal Surgery

Surgical Blood LossTransfusion-dependent AnemiaAbdomen Disease
Ulrich Ronellenfitsch, MD850 enrolled2 locationsNCT06414031
Recruiting
Phase 3

Tranexamic Acid in Adult Spinal Deformity Surgery

Blood Loss, SurgicalSpinal DeformityDegenerative Lumbar Spinal Stenosis
Hospital for Special Surgery, New York100 enrolled1 locationNCT03553186
Recruiting
Not Applicable

PVI vs ESP Block for Reducing Bleeding and Postoperative Pain in Lumbar Fusion Surgery.

Postoperative PainSurgical Blood LossLumbar Spinal Fusion Surgery
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau62 enrolled2 locationsNCT07550114
Recruiting
Not Applicable

Reducing Blood Loss During Myomectomy:Uterine Artery Ligation Vs Pericervical Tourniquet

blood lossMyoma;Uterus
Cairo University40 enrolled1 locationNCT07526311
Recruiting

Hemophilia A Research Program

PregnancyHemophilia APregnancy Complications+10 more
University of Washington500 enrolled1 locationNCT07414511
Recruiting

The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma

MicrobiomeCritical IllnessTrauma+3 more
University of Florida275 enrolled3 locationsNCT06606119
Recruiting
Not Applicable

Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy

Uterine Fibroids (Leiomyoma)MyomectomyMyomectomy; Surgical Blood Loss
Alexandria University60 enrolled2 locationsNCT07352761
Recruiting
Not Applicable

Tranexamic Acid in Pediatric Undergoing Proximal Femoral Osteotomies and/or Acetabular Osteotomy

Orthopedic DisorderPediatricIntraoperative Blood loss.
Assiut University400 enrolled1 locationNCT04811313
Recruiting
Phase 2

Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony

Blood Loss, SurgicalBlood Loss, PostoperativeUterine atony
University of Michigan140 enrolled1 locationNCT07217899
Recruiting
Phase 2

Oxytocin Pharmacokinetics and Pharmacodynamics

blood lossPost Partum HemorrhageCesarean Section Complications
University of Chicago100 enrolled2 locationsNCT05488457
Recruiting
Not Applicable

Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol.

Myomectomy; Surgical Blood LossMyoma;Uterus
University Hospital, Clermont-Ferrand80 enrolled1 locationNCT06882824
Recruiting
Not Applicable

Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery

Adverse Drug EventFibrinolysis; HemorrhageBlood Coagulation Disorder+2 more
University of Ioannina150 enrolled1 locationNCT07164300
Recruiting

Transfusion Surveillance in Anaesthesia

blood lossAnesthesiaSide Effect+5 more
Erasme University Hospital50,000 enrolled1 locationNCT06403163
Recruiting

Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions.

Pain, PostoperativeCystectomyAnaemia+3 more
Goethe University60 enrolled1 locationNCT07008261
Recruiting
Phase 4

Single-dose Intravenous Iron Therapy for Anemia After Orthopaedic Trauma

FractureAcute Blood Loss Anemia
Oregon Health and Science University150 enrolled1 locationNCT05292001
Recruiting
Phase 4

Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes

blood lossHemorrhageDilation and Evacuation+2 more
University of California, San Diego276 enrolled2 locationsNCT06820177